Recent Developments in Mpox Prevention and Treatment Options

Shiza Malik, Tahir Ahmad, Omar Ahsan, Khalid Muhammad, Yasir Waheed

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)


Human mpox is an emerging epidemic in the world. The monkey pox virus (MPXV) belongs to the same family of zoonotic Orthopoxviridae as that of the smallpox virus and exhibits similar clinical symptomology. Information regarding its diagnostics, disease epidemiology, surveillance, preventive methods, and treatment strategies are being collated with time. The purpose of this review is to trace the recent events in the scientific platform that have defined new preventive and treatment strategies against mpox. A methodological approach has been used to gather data from the latest literature to comprehensively overview the emerging treatment options. The results portion will cover details regarding the prevention of mpox. It will also shed light on a brief description of contemporary vaccines and antiviral agents that have been evaluated for their treatment potential since the emergence of the mpox threat. These treatment options are setting the pace for controlling the widespread monkeypox infection. However, the limitations attached to these treatment strategies need to be tackled quickly to increase their efficacy so that they can be deployed on a large scale for the prevention of this epidemic becoming another pandemic in this decade.

Original languageEnglish
Article number500
Issue number3
Publication statusPublished - Mar 2023


  • MPXV
  • antiviral agents
  • clinical management
  • mpox
  • novel therapeutic
  • therapeutics
  • vaccines

ASJC Scopus subject areas

  • Immunology
  • Pharmacology
  • Drug Discovery
  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Recent Developments in Mpox Prevention and Treatment Options'. Together they form a unique fingerprint.

Cite this